Vera M. Hillewaert

Beerse, VLG, Belgium

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 17 publications

Pharmacokinetics of JNJ-73763989 and JNJ-56136379 (Bersacapavir) in Participants With Moderate Hepatic Impairment.

Pharmacokinetics of JNJ-73763989 and JNJ-56136379 (Bersacapavir) in Participants With Moderate Hepatic Impairment.

Journal: Journal of clinical pharmacology

Published: November 17, 2022

JNJ-73763989 pharmacokinetics and safety: Liver-targeted siRNAs against hepatitis B virus, in Japanese and non-Japanese healthy adults, and combined with JNJ-56136379 and a nucleos(t)ide analogue in patients with chronic hepatitis B.

JNJ-73763989 pharmacokinetics and safety: Liver-targeted siRNAs against hepatitis B virus, in Japanese and non-Japanese healthy adults, and combined with JNJ-56136379 and a nucleos(t)ide analogue in patients with chronic hepatitis B.

Journal: Antiviral therapy

Published: June 13, 2022

Drug-Drug Interactions With the Hepatitis B Virus Capsid Assembly Modulator JNJ-56136379 (Bersacapavir).

Drug-Drug Interactions With the Hepatitis B Virus Capsid Assembly Modulator JNJ-56136379 (Bersacapavir).

Journal: Clinical pharmacology in drug development

Published: April 14, 2022

Capillary microsampling in clinical studies: opportunities and challenges in two case studies.

Capillary microsampling in clinical studies: opportunities and challenges in two case studies.

Journal: Bioanalysis

Published: July 07, 2020

Population pharmacokinetics of trabectedin in adolescent patients with cancer.

Population pharmacokinetics of trabectedin in adolescent patients with cancer.

Journal: Cancer chemotherapy and pharmacology

Published: December 03, 2018

Single- and multiple-dose pharmacokinetics and safety of pimodivir, a novel, non-nucleoside polymerase basic protein 2 subunit inhibitor of the influenza A virus polymerase complex, and interaction with oseltamivir: a Phase 1 open-label study in healthy volunteers.

Single- and multiple-dose pharmacokinetics and safety of pimodivir, a novel, non-nucleoside polymerase basic protein 2 subunit inhibitor of the influenza A virus polymerase complex, and interaction with oseltamivir: a Phase 1 open-label study in healthy volunteers.

Journal: British journal of clinical pharmacology

Published: April 03, 2018

Pharmacokinetics, Antiviral Activity, and Safety of Rilpivirine in Pregnant Women with HIV-1 Infection: Results of a Phase 3b, Multicenter, Open-Label Study.

Pharmacokinetics, Antiviral Activity, and Safety of Rilpivirine in Pregnant Women with HIV-1 Infection: Results of a Phase 3b, Multicenter, Open-Label Study.

Journal: Infectious diseases and therapy

Published: November 08, 2017

Pharmacokinetic Interactions between Simeprevir and Ledipasvir in Treatment-Naive Hepatitis C Virus Genotype 1-Infected Patients without Cirrhosis Treated with a Simeprevir-Sofosbuvir-Ledipasvir Regimen.

Pharmacokinetic Interactions between Simeprevir and Ledipasvir in Treatment-Naive Hepatitis C Virus Genotype 1-Infected Patients without Cirrhosis Treated with a Simeprevir-Sofosbuvir-Ledipasvir Regimen.

Journal: Antimicrobial agents and chemotherapy

Published: June 29, 2017

Pharmacokinetics of Total and Unbound Etravirine in HIV-1-Infected Pregnant Women.

Pharmacokinetics of Total and Unbound Etravirine in HIV-1-Infected Pregnant Women.

Journal: Journal of acquired immune deficiency syndromes (1999)

Published: May 10, 2016

Evaluation of Three Amorphous Drug Delivery Technologies to Improve the Oral Absorption of Flubendazole.

Evaluation of Three Amorphous Drug Delivery Technologies to Improve the Oral Absorption of Flubendazole.

Journal: Journal of pharmaceutical sciences

Published: December 17, 2015

Pharmacokinetics of once-daily darunavir/ritonavir in HIV-1-infected pregnant women.

Pharmacokinetics of once-daily darunavir/ritonavir in HIV-1-infected pregnant women.

Journal: HIV medicine

Published: November 04, 2015

Sample Management: Recommendation for Best Practices and Harmonization from the Global Bioanalysis Consortium Harmonization Team.

Sample Management: Recommendation for Best Practices and Harmonization from the Global Bioanalysis Consortium Harmonization Team.

Journal: The AAPS journal

Published: June 02, 2015

Showing 1-12 of 17

Last Updated: 09/26/2026